# DELPHI in Subjects at Risk for Stroke and Dementia

> **NCT03884647** · — · COMPLETED · sponsor: **QuantalX Neuroscience** · enrollment: 335 (actual)

## Conditions studied

- Stroke
- Hypertension
- Diabete Mellitus
- Dyslipidemias
- Sleep Disorder
- Smoking
- Overweight and Obesity
- Familial Alzheimer Disease
- Atrial Fibrillation
- Cardiac Disease
- Cognitive Impairment
- Transient Ischemic Attack

## Interventions

- **DEVICE:** DELPhI system

## Key facts

- **NCT ID:** NCT03884647
- **Lead sponsor:** QuantalX Neuroscience
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-01
- **Primary completion:** 2022-05-06
- **Final completion:** 2022-05-06
- **Target enrollment:** 335 (ACTUAL)
- **Last updated:** 2022-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03884647

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03884647, "DELPHI in Subjects at Risk for Stroke and Dementia". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03884647. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*